Biotech

Welcome to the 'Biotech' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Biotech'.

Latest blogosphere posts tagged “Biotech”

• Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018

  
  advanced medical technologies — Authority: 128
  Publishing a new report in December 2009:  Tissue Engineering, Cell Therapy and Transplantation: Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018. This report examines the status of technologies, applications and markets for tissue ...
  19 hours ago

• Nanoparticles For Gene Therapy

  
  FuturePundit — Authority: 125
  An MIT press release about the use of nanoparticles to deliver gene therapy contains an interesting statistic about the size of the overall effort to develop clinically useful gene therapies: In the United States alone almost 1000 gene therapy clinical trials are underway. Thats a surprisingly large number. Is it ...
  1 day ago

• Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M

  
  Xconomy — Authority: 712
  Biotech , deals , startups Luke Timmerman wrote: Ironwood Pharmaceuticals is gearing up for the possibility of an IPO. The Cambridge, MA-based developer of a new treatment for bowel disorders like for irritable bowel syndrome and chronic constipation said it may raise as much as $172.5 million from ...
  1 day ago

• A Little Intermittent Fasting Research

  
  Fight Aging! — Authority: 466
  The dominant topic for this past week of posts was the beneficial biochemistry of eating less ; changes to gene expression and metabolism, enhanced health and extended longevity. That wasnt an intentional choice - it just worked out that way as various items caught my eye. All the same, why not round it off with an ...
  1 day ago

• ACT Seeks hESC Clinical Trial

  
  California Stem Cell Report — Authority: 135
  Advanced Cell Technology has become the second U.S. company to seek permission to begin clinical trials for a therapy based on human embryonic stem cells.The Santa Monica, Ca., firm said yesterday that it has applied to the FDA to start trials aimed at reversing vision loss with retinal cells created from the stem ...
  1 day ago

• Anti-Smoking Vaccine Is Nearing the Market

  
  Slashdot — Authority: 160
  eldavojohn writes "Almost 6 years ago we discussed a vaccine to help people quit smoking as it entered human clinical trials. Now it looks like the finishing touches have been put on a deal that will go into effect once phase III testing of the drug now called NicVAX is completed. NicVAX was developed by Nabi ...
  1 day ago

• MICROBIOLOGY JOBS-PANACEA BIOTEC DELHI

  
  VFRESHERS — Authority: 159
  Microbiology Scientific Officer Job Positions India at Delhi – Panacea BiotecJob Title : Scientific Officer – Vaccine ProductionAbout Company :Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, ...
  1 day ago

• Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder

  
  Xconomy — Authority: 712
  Biotech , Drugs , Multiple Sclerosis Luke Timmerman wrote: After a bitter standoff earlier this year with billionaire investor Carl Icahn over alleged mismanagement , Cambridge, MA-based Biogen Idec now faces another sharp attack from a major shareholder. New York-based HealthCor Management, a hedge ...
  1 day ago

• Delft Researchers Create New Metabolic Pathway in Yeast to Boost Ethanol Yield from Biomass Waste

  
  Green Car Congress — Authority: 566
  Researchers from Delft University of Technology have engineered the yeast Saccharomyces cerevisiae to increase ethanol yield from biomass waste by eliminating production of glycerol (glycerol production is essential to reoxidize NADH produced in biosynthetic processes), reoxidizing NADH instead by the reduction of ...
  1 day ago

• Dendreon FDA Deadline Set For May 1

  
  Xconomy — Authority: 712
  Biotech , cancer , Drugs Luke Timmerman wrote: Seattle-based Dendreon (NASDAQ: DNDN ), the developer of what it hopes will be the first FDA-approved treatment to actively stimulate the immune system against cancer, said today the U.S. regulatory agency has received its amended application and set a ...
  2 days ago

• The Dean Thinks Swine Flu Profits Could Soon Be Airborne

  
  CollegeStock - The Dean of College Stocks — Authority: 140
  According to the Center for Disease Control and Prevention (CDC) FluView, a weekly influenza surveillance report, there have been over 40,000 confirmed H1N1 Swine Flu cases in the United States as of November 7th. This data also shows that pneumonia and influenza related deaths have exceeded the epidemic threshold for ...
  2 days ago

• Lawmakers Call For Inquiry Into Pharmaceutical Company Price Hikes

  
  Health News from Medical News Today — Authority: 724
  Reuters: "Congressional Democrats are seeking government investigations into recent price increases of brand-name prescription drugs, as Congress finalizes an overhaul of the healthcare system.
  2 days ago

• Metcalfe Reflects on $2.7B 3Com Buyout, $30M More for Fate Therapeutics, & More Boston Deals News

  
  Xconomy — Authority: 712
  deals , VC , mergers and acquisitions Ryan McBride wrote: Dealmakers appear to be getting their business done before the week of Thanksgiving—because we’ve seen a decent stream of deal closings involving Boston-area life sciences and tech companies over the past week or so. —Framingham, MA-based ...
  2 days ago

• Under the Radar Deals: 12 Northwest Financings You Haven’t Heard About

  
  Xconomy — Authority: 712
  deals , startups , Investments Gregory T. Huang wrote: We hope to make this a regular feature in our Xconomy cities. It’s a look at small financings of private companies in tech, life sciences, and cleantech. These are deals in the roughly $100,000 to $1 million range, and they’re increasingly where ...
  2 days ago

• Biotech Stock Mailbag: FDA Playbook

  
  TheStreet.com — Authority: 560
  Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.
  2 days ago

• Global honour for Pune univarsity’s biotech students

  
  The Punekar — Authority: 150
  Times of India : A seven-member team of the University of Pune’s (UoP) five-year integrated M.Sc biotechnology course outclassed their more established counterparts from globally-renowned universities to win a bronze medal at the annual international genetically-engineered machines (iGEM) competition at the ...
  2 days ago

• Three Blows Against the Tyranny of Expensive Experiments

  
  Omics! Omics! — Authority: 117
  Second generation sequencing is great, but one of its major issues so far is that the cost of one experiment is quite steep. Just looking at reagents, going from a ready-to-run library to sequence data is somewhere in the neighborhood of $10K-25K on 454, Illumina, Helicos or SOLiD (Im willing to take corrections on ...
  2 days ago

• Scripps Loring Teams with International Stem Cell Corp.

  
  California Stem Cell Report — Authority: 135
  The Scripps Research Institute and scientist Jeanne Loring are collaborating with International Stem Cell Corp. of Oceanside, Ca., to study parthenogenic stem cells and their potential therapeutic use, it was announced today.In a news release from the company, Loring, director of the Center for Regenerative Medicine ...
  2 days ago

• Another Candidate for Lynchpin Gene Controlling Calorie Restriction

  
  Fight Aging! — Authority: 466
  One of the better research outcomes a biologist can hope for is to find that a particular mechanism, disease, or benefit has a single point of control somewhere in its web of interlinked genes and feedback loops. A single gene or protein that acts as a switch or a dial, and has no or few entanglements with other ...
  2 days ago

• Omeros Banks on First FDA Filing Next Year, Plans to “Unlock” Inaccessible Drug Targets

  
  Xconomy — Authority: 712
  Biotech , Knee Surgery , Drugs Luke Timmerman wrote: Seattle-based Omeros expects to apply for FDA clearance to start selling its first product by the second half of next year, and it also hoping to strike at least one partnership over the next couple of years with a bigger drugmaker, CEO Greg Demopulos ...
  2 days ago

Comments about Biotech